DL Life Logo SEPTEMBER 11,2014 - - - - 123,175 AMERICANS ARE CANDIDATES ON THE UNOS TRANSPLANT WAIT LIST DL Life Logo 101,170 waiting for a kidney DL Life Logo 15,714 wait-listed for a liver DL Life Logo 1,181 waiting for a pancreasDL Life Logo 2,052 needing a Kidney-PancreasDL Life Logo 4,035 waiting for a life-saving heartDL Life Logo 1,629 waiting for a lungDL Life Logo 53 waiting for a heart-lungDL Life Logo 259 waiting for small bowelDL Life Logo One organ donor has the opportunity to save up to 8 lives DL Life Logo One tissue donor has the opportunity to save and -or enhance the lives of 50 or more individuals DL Life Logo You have the power to SAVE Lives by becoming an organ, eye and tissue donor, so what are you waiting for? To learn how to register click HEREDL Life Logo

Thursday, February 9, 2012

Step towards creating intestine transplant using patient's own cells

Medical Express

(Medical Xpress) -- Doctors at the UCL Institute of Child Health have made progress towards engineering donated intestines, so that they can be implanted without rejection.

Tissue engineering involves using a donated organ, stripping it of cells from the donor, and rebuilding the organ using the recipient’s own stem cells. The resulting organ does not trigger the recipient patient’s immune system.
The technique has been used clinically in humans, with the world’s first stem cell assisted trachea transplant in a child at Great Ormond Street and with clinical successes in adults at other centres. Collaborators at other centres have also succeeded in similar development of bladders and urethras, including clinical success in humans.
However, the intestine poses an issue in that in order to work, it is necessary to replicate the complex structure of the intestinal villi. Previous successes with the technology have been in inherently less complex organs.
Dr Paolo de Coppi and colleagues have demonstrated a technique in a rat model which successfully retains these structures, by removing the original cells through the vascular system. The resulting scaffold should be suitable for stem cell use and subsequent transplant. The work is published inBiomaterials.
Paolo de Coppi, Clinical Lecturer and Consultant at the UCL Institute of Child Health/Great Ormond Street Hospital, said: “Management of intestinal failure through conventional means poses a number of problems for the patient. The option of an engineered intestine, made partly from the patient’s own , would be an important clinical advance. This paper represents a step forward and we hope to publish promising studies with human tissue in due course.”
This investigation was supported by Great Ormond Street Hospital charity, the Fondation Eugenio Litta (Geneva, Switzerland), the Medical Research Council, the Royal College of Surgeons of England, the Sparks Children’s Medical Charity, the British Foreign Office for the UK/USA Stem Cell Collaboration Award and the Mittal Research Fund. The researchers would also like to thank the Royal Society/Wolfson Foundation for the  laboratory refurbishment grant obtained for the Pediatric Surgery Department in the UCL Institute of Child Health.
Provided by University College London (news : web)

No comments: